| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| ELVN, IMRA | Enliven Therapeutics, Inc. | Chief Scientific Officer | $20.8M | -$2.32M | -10% | Nov 19, 2025 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|